Literature DB >> 23147739

Inhibition of Streptococcus pneumoniae penicillin-binding protein 2x and Actinomadura R39 DD-peptidase activities by ceftaroline.

Astrid Zervosen1, André Zapun, Jean-Marie Frère.   

Abstract

Although the rate of acylation of a penicillin-resistant form of Streptococcus pneumoniae penicillin-binding protein 2x (PBP2x) by ceftaroline is 80-fold lower than that of its penicillin-sensitive counterpart, it remains sufficiently high (k(2)/K = 12,600 M(-1) s(-1)) to explain the sensitivity of the penicillin-resistant strain to this new cephalosporin. Surprisingly, the Actinomadura R39 DD-peptidase is not very sensitive to ceftaroline.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23147739      PMCID: PMC3535952          DOI: 10.1128/AAC.01593-12

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN: 0066-4804            Impact factor:   5.191


  17 in total

1.  Genetics of resistance to third-generation cephalosporins in clinical isolates of Streptococcus pneumoniae.

Authors:  R Muñoz; C G Dowson; M Daniels; T J Coffey; C Martin; R Hakenbeck; B G Spratt
Journal:  Mol Microbiol       Date:  1992-09       Impact factor: 3.501

2.  Identical penicillin-binding domains in penicillin-binding proteins of Streptococcus pneumoniae clinical isolates with different levels of beta-lactam resistance.

Authors:  Laurent Chesnel; Raphaël Carapito; Jacques Croizé; Otto Dideberg; Thierry Vernet; André Zapun
Journal:  Antimicrob Agents Chemother       Date:  2005-07       Impact factor: 5.191

3.  Automated analysis of enzyme inactivation phenomena. Application to beta-lactamases and DD-peptidases.

Authors:  F De Meester; B Joris; G Reckinger; C Bellefroid-Bourguignon; J M Frère; S G Waley
Journal:  Biochem Pharmacol       Date:  1987-07-15       Impact factor: 5.858

4.  Penicillin binding protein 2x as a major contributor to intrinsic beta-lactam resistance of Streptococcus pneumoniae.

Authors:  M Jamin; R Hakenbeck; J M Frere
Journal:  FEBS Lett       Date:  1993-09-27       Impact factor: 4.124

5.  Serine-type D-Ala-D-Ala peptidases and penicillin-binding proteins.

Authors:  B Granier; M Jamin; M Adam; M Galleni; B Lakaye; W Zorzi; J Grandchamps; J M Wilkin; C Fraipont; B Joris
Journal:  Methods Enzymol       Date:  1994       Impact factor: 1.600

6.  Mosaic genes and mosaic chromosomes: intra- and interspecies genomic variation of Streptococcus pneumoniae.

Authors:  R Hakenbeck; N Balmelle; B Weber; C Gardès; W Keck; A de Saizieu
Journal:  Infect Immun       Date:  2001-04       Impact factor: 3.441

7.  Interspecies recombinational events during the evolution of altered PBP 2x genes in penicillin-resistant clinical isolates of Streptococcus pneumoniae.

Authors:  G Laible; B G Spratt; R Hakenbeck
Journal:  Mol Microbiol       Date:  1991-08       Impact factor: 3.501

8.  Penicillin-binding protein 2x of Streptococcus pneumoniae: enzymic activities and interactions with beta-lactams.

Authors:  M Jamin; C Damblon; S Millier; R Hakenbeck; J M Frère
Journal:  Biochem J       Date:  1993-06-15       Impact factor: 3.857

9.  Identification of a structural determinant for resistance to beta-lactam antibiotics in Gram-positive bacteria.

Authors:  N Mouz; E Gordon; A M Di Guilmi; I Petit; Y Pétillot; Y Dupont; R Hakenbeck; T Vernet; O Dideberg
Journal:  Proc Natl Acad Sci U S A       Date:  1998-11-10       Impact factor: 11.205

10.  Synthesis and evaluation of boronic acids as inhibitors of Penicillin Binding Proteins of classes A, B and C.

Authors:  Astrid Zervosen; André Bouillez; Alexandre Herman; Ana Amoroso; Bernard Joris; Eric Sauvage; Paulette Charlier; André Luxen
Journal:  Bioorg Med Chem       Date:  2012-04-16       Impact factor: 3.641

View more
  3 in total

1.  Activity of ceftaroline against Enterococcus faecium PBP5.

Authors:  Xavier Henry; Oliver Verlaine; Ana Amoroso; Jacques Coyette; Jean-Marie Frère; Bernard Joris
Journal:  Antimicrob Agents Chemother       Date:  2013-09-23       Impact factor: 5.191

2.  Discovery of Pyrrolidine-2,3-diones as Novel Inhibitors of P. aeruginosa PBP3.

Authors:  Arancha López-Pérez; Stefan Freischem; Immanuel Grimm; Oliver Weiergräber; Andrew J Dingley; María Pascual López-Alberca; Herbert Waldmann; Waldemar Vollmer; Kamal Kumar; Cuong Vuong
Journal:  Antibiotics (Basel)       Date:  2021-05-04

Review 3.  Glycosyltransferases and Transpeptidases/Penicillin-Binding Proteins: Valuable Targets for New Antibacterials.

Authors:  Eric Sauvage; Mohammed Terrak
Journal:  Antibiotics (Basel)       Date:  2016-02-17
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.